Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 255 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2926 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
13 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2021-07-08 | 2022-10-18 | 142201 |
| TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2021-12-02 | 2023-01-26 | 150409 |
| TEVA-SUMATRIPTAN DF | 25MG | TABLET | Resolved | 2022-10-28 | 2022-11-12 | 173028 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176845 |
| TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2025-04-04 | 2025-05-08 | 254127 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2025-07-18 | 2025-11-13 | 263119 |
| TEVA-SUMATRIPTAN DF | 25MG | TABLET | Resolved | 2025-07-18 | 2025-10-16 | 263146 |
| TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2025-07-18 | 2025-10-23 | 263149 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Actual shortage | 2025-11-27 | 2025-12-11 | 272766 |
| TEVA-TADALAFIL | 5MG | TABLET | Resolved | 2019-08-22 | 2019-09-26 | 92160 |
| TEVA-TADALAFIL | 10MG | TABLET | Resolved | 2019-09-05 | 2019-09-27 | 93143 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2019-11-14 | 2020-01-17 | 98738 |
| TEVA-TADALAFIL | 2.5MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107955 |
| TEVA-TADALAFIL | 5MG | TABLET | Resolved | 2020-03-06 | 2020-07-23 | 107958 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2020-04-23 | 2020-07-23 | 113037 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2020-10-01 | 2020-10-08 | 125479 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2021-03-04 | 2021-04-01 | 135120 |
| TEVA-TADALAFIL | 5MG | TABLET | Resolved | 2021-05-06 | 2021-05-27 | 138910 |
| TEVA-TADALAFIL | 2.5MG | TABLET | Resolved | 2021-05-20 | 2021-05-27 | 139758 |
| TEVA-TADALAFIL | 10MG | TABLET | Resolved | 2021-05-27 | 2021-07-09 | 140042 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ENALAPRIL | 8MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258676 |
| ACT ENALAPRIL | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258682 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258697 |
| ACT FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258703 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| TEVA-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266377 |
| TEVA-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266380 |
| TEVA-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266383 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |